Research Grants

Current Grants

R01 AI083636-01 | (PI: A. Salomon) | 06/15/10 to 05/31/16 NIH/NIAID
“Phosphoproteomic Analysis of T Cell Activation Pathways”
The goal of this proposal is the analysis of signaling pathways in human T cells utilizing a combination of novel phosphoproteomic techniques combined with traditional approaches.
Role: PI

5P20 GM103421-11 | (PI: B. Ramratnam) | 05/01/15 to 04/30/20 NIH/GM
“COBRE Center for Cancer Research Development”
CCRD will promote the expansion of basic cancer research by creating a supportive research environment that facilitates the transition of promising scientists into independent investigators.
Role: Subcontract PI, Director of Proteomic Core Facility

5T32 GM007601-36 | (PI: K. Mowry) | 07/01/15 to 06/30/20 NIH/GM
“Training in Molecular and Cell Biology andBiochemistry”
This competing renewal application requests continuation of support for years 36-40 for training in Molecular and Cell Biology and Biochemistry for an exceptional cohort of predoctoral students in the Brown University Graduate Program in Molecular Biology, Cell Biology and Biochemistry (MCB)
Role: Co-PI

Past Grants

R01 AI083636-01 | (PI: A. Salomon) | 6/1/11 to 5/31/12 | NIH/NIAID
“Phosphoproteomic Analysis of T Cell Activation Pathways”
This R01 supplement provides direct cost for user fees for the Salomon lab on the Orbitrap VELOS mass spectrometer in the EPSCoR Proteomic Core Facility.
Role: PI

Vertex Pharmaceuticals| (PI: A. Salomon) | 6/1/12 to 5/31/14
“Quantitative phosphoproteomic dissection of bidirectional signaling pathways”
This R01 supplement provides $37,908 direct cost for user fees for the Salomon lab on the Orbitrap VELOS mass spectrometer in the EPSCoR Proteomic Core Facility.
Role: PI

Hyundai Hope on Wheels | (PI: R. Altura) | 12/1/11-11/30/12“Identification of the phosphoproteome in high and low risk neuroblastoma tumors”The goal of this proposal is to obtain a phosphoproteomic signature of neuroblastoma tumors.”      Role: Collaborator

R01 AG024360-06A1 | (PI: M. Tatar) | 4/1/11 to 3/31/16 | NIH/NIA
“Functions and Interactions of DFOXO in Drosophila Aging”
The work proposed in this renewal aims to understand how the several different insulin like proteins of Drosophila work to regulate aging and alternatively, metabolism.
Role: Collaborator

R21 AI083908-02 | (PI: A. Salomon) | 07/17/09 to 06/30/11 | NIH/NIAID
“Towards a Molecular Signature of Neutrophil Priming”
The goal of this proposal is the analysis of signaling pathways in human neutrophil priming utilizing novel phosphoproteomic techniques developed in our lab.

NIH COBRE grant #2P20RR015578 | 07/01/05 to 02/28/10
“Center for Cancer Signaling Networks” Dr. John Sedivy PI
Program Project 3: “High-throughput Proteomic Analysis of Signaling Pathways”

Beckman Young Investigator Award | 09/01/06 to 08/31/10
“Phosphoproteomic analysis of cellular signaling pathways in allergy and asthma”
Total direct costs to Salomon lab 266,000$ over 4 years

NIH R21 grant #1R21DA021765-01 | 09/31/06 to 09/30/08
“The Neuronal Nicotinic Acetylcholine Receptor Interactome via a Knock-In Mouse” (PI:Hawrot)